Newsletters

  • All
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
All
  • All
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
CARB-XR&D Insight

CARB-X is seeking additional accelerators to expand support for its pipeline

Dear All: It is exciting to see that CARB-X today announced that it is seeking to partner with up to 6 additional …

Read More >
Push/PullWonkish

Push! Pull! Push! Pull! / Highlights from Davos 2018

Dear All: Three important documents were released at / during / around the World Economic Forum meeting that occurred this …

Read More >
R&D Insight

Updated Pew Pipeline analysis of both traditional and non-traditional antimicrobial agents in development

Dear All: To start the new year, I’ve learned that Pew has updated their pipeline analysis. First released in Feb …

Read More >
WHO

WHO Priority Pathogens List paper is published; Industry action report to be released

Dear All: First, the methods behind the WHO Priority Pathogens List (PPL, released on 25 Feb 2017) have now been published by Tacconelli et …

Read More >
FDAR&D Insight

Debut of FDA Susceptibility Test Interpretive Criteria (STIC) website

Dear All: I knew that the idea of an online and frequently updated website for FDA-recognized Susceptibility Test Interpretive Criteria …

Read More >
JobsRFPs

Research opportunity: Two RFPs from Wellcome Trust in support of the UN IACG

Dear All: I have just learned that Wellcome Trust is seeking applications to address an RFP (Request for Proposal) for …

Read More >
FDAR&D Insight

FDA AdComm #2 on inhaled ciprofloxacin (11 Jan 2018); IMI Call for AMR diagnostics (28 Feb 2018 deadline)

Dear All: Two new events on the near-term horizon. First, FDA has announced an Antimicrobial Drugs Advisory Committee for 11 Jan 2018  …

Read More >
FDAGovernment Action

EMA-FDA-PMDA action + Podcasts (CDD, Pew) + NEJM on non-inferiority

Dear All: Several updates today, all on the theme of good things to know or share! First, EMA, FDA, and PMDA …

Read More >
R&D Insight

4-7 Sep 2018: ESCMID-ASM Conference #3 on AMR (initial flyer)

Dear All: Now available is the initial flyer for next year’s ESCMID-ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance. …

Read More >
R&D Insight

13-19 Nov 2017: Handle (antibiotics) with Care! — World Antibiotic Awareness Week

​Dear All: This is your heads-up about next week’s World Antibiotic Awareness Week. Themed “Learn how to handle antibiotics with care,” …

Read More >
FDAR&D Insight

7 Nov 2017 FDA VRBPAC: Pfizer’s S. aureus vaccine — do results in one population generalize?

Addendum: This is the second in a 3-newsletters series on this topic. Go here for the first newsletter and here …

Read More >
FDAR&D Insight

Summary of funding initiatives (Simpkin et al.) + E9(R1) Statistical methods update (FDA)

Dear All: Two updates today. First, our colleagues at London School of Economics have just published a review of antibiotic innovation incentives that includes …

Read More >
Push/Pull

Incentives for antibiotics: Recent papers, with an emphasis on Pull

Dear All:  For your weekend reading list, I have some papers on the topic of (mostly pull) incentives for antibiotics. …

Read More >
CDC

CDC funds more than 20 AMR-focused projects!

​Dear All:  CDC has today announced $9m in funding for more than 20 new projects focused on slowing or combating antimicrobial resistance. …

Read More >
FDAR&D Insight

7 Nov 2017 FDA VRBPAC: Clinical development plan for a S. aureus vaccine

Addendum: This is the first in a 3-newsletters series on this topic. Go here and here for the next two …

Read More >
Can you help?

Preclinical pipeline overview / Help fund a movie about AMR!

Dear All: Two things today. First, Ursula Theuretzbacher, Miloje Savic, Christine Ardal, and Kevin Outterson have published in Nature Reviews Drug Discovery a brief …

Read More >
FDAR&D Insight

16 Nov FDA AdComm – Inhaled ciprofloxacin for non-CF bronchiectasis

Dear All:  A Federal Register notice has been released announcing a 16 Nov 2017 FDA Antimicrobial Drugs Advisory Committee meeting to review Bayer’s …

Read More >
R&D Insight

6 Nov 2017 BAARN (Boston Area Antimicrobial Resistance Network) + 7-8 Nov BARDA Industry Days

Dear All: Early November will be busy! First, BAARN is having their annual meeting in the Boston area on 6 Nov. See …

Read More >
R&D InsightWHO

WHO Pipeline Review: “The world is running out of antibiotics”

Dear All:  Released just a few hours ago in parallel with the UN General Assembly meetings, WHO has produced a …

Read More >
Wellcome Trust

International AMR Action! 21 Sep Wellcome Trust-UNGA event / 12-13 Oct Call to Action (Berlin)

Dear All:  The international conversation continues apace following the recent DRIVE-AB meeting on antibiotic incentives. There are two further important meetings coming …

Read More >
Scroll to Top